Details for New Drug Application (NDA): 072928
✉ Email this page to a colleague
The generic ingredient in LORAZEPAM is lorazepam. There are eleven drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
Summary for 072928
| Tradename: | LORAZEPAM |
| Applicant: | Watson Labs |
| Ingredient: | lorazepam |
| Patents: | 0 |
Suppliers and Packaging for NDA: 072928
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LORAZEPAM | lorazepam | TABLET;ORAL | 072928 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-3427 | 0093-3427-01 | 100 TABLET in 1 BOTTLE, PLASTIC (0093-3427-01) |
| LORAZEPAM | lorazepam | TABLET;ORAL | 072928 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-3427 | 0093-3427-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0093-3427-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Oct 31, 1991 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
